In:
International Journal of Cancer, Wiley, Vol. 146, No. 4 ( 2020-02-15), p. 1164-1173
Kurzfassung:
What's new? Colon cancer screening currently focusses on stool samples, but precancerous adenomas are not reliably recognized by occult blood‐based or immunochemical tests. Here the authors identify three plasma circulating miRNA‐based signatures that can detect among the individuals positive for the fecal immunochemical test those with precancerous and cancerous lesions. They propose that a blood test based on these signatures could be an additional analysis in individuals with positive fecal test to limit the number of colonoscopies to those likely to benefit most.
Materialart:
Online-Ressource
ISSN:
0020-7136
,
1097-0215
Sprache:
Englisch
Verlag:
Wiley
Publikationsdatum:
2020
ZDB Id:
218257-9
ZDB Id:
1474822-8
